AstraZeneca

We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

Forum

About

AstraZeneca Challenge: Digital Health Solutions for Clinical Trial Acceleration

AstraZeneca is seeking collaboration partners who can help us improve clinical outcomes and disease management for the benefit of both patients and healthcare professionals.

AstraZeneca Challenge: Robust Online In Vivo Measurement of Biomarker Concentrations

AstraZeneca seeks to develop a generic device that can allow real time measurement of the concentrations of multiple biomarkers in blood and possibly other tissues.

AstraZeneca Challenge: Determination of Free Drug Concentration in Lung

AstraZeneca wishes to identify a method that can solve current limitations and provide valuable insight into understanding of inhaled drugs behavior in vivo.

AstraZeneca Challenge: In Vitro System to Assess Gastrointestinal Toxicity

AstraZeneca seeks an in vitro model to investigate gastrointestinal toxicity onset and recovery.

AstraZeneca Challenge: Automating Drug Administration and Removal in Multiwell Plates

The challenge seeks a system compatible with multiwell plates that automates the time-dependent changes in drug concentration that define dynamic pharmacokinetics.

AstraZeneca Challenge: In Vitro Models of Glomerular Function

AstraZeneca is looking for approaches to develop a glomerular model system.

AstraZeneca Challenge: Retrievable Device for Islet Transplantation

AstraZeneca is searching for a simple device for the transplantation and subsequent retrieval of human islets to support in vivo testing of therapeutic agents.

AstraZeneca Challenge: In Vitro Proximal Tubule Model Systems

AstraZeneca is seeking innovative approaches to developing a model system of the proximal tubule in vitro.

AstraZeneca Challenge: Developing Clinically-Relevant Models for Diffuse Large B Cell Lymphoma

AstraZeneca is interested in innovative proposals to create suitable preclinical models of DLBCL.

AstraZeneca Challenge: Quantitative Measure of Covalent Binding

AstraZeneca desires an innovative approach for the quantitative measurement of covalent binding of metabolites to cellular proteins.

AstraZeneca Challenge: A Pressure-Sensing Core for Cardiac or Vascular Microtissues

This challenge is interested in solutions that provide a core to the spheroids that senses and reports pressure and compound-induced changes in pressure.